1. DNA Methylation as a Therapeutic Target for Bladder Cancer
   Sandra P. Nunes et al, 2020, Cells CrossRef
2. MiR-3682-3p promotes esophageal cancer progression by targeting FHL1 and activating the Wnt/β-catenin signaling pathway
   Yuxin Cai et al, 2024, Cellular Signalling CrossRef
3. Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer
   Xiaoying Chen et al, 2024, Functional & Integrative Genomics CrossRef